Subsequent Events (Details) - USD ($) $ in Millions |
4 Months Ended | |||
|---|---|---|---|---|
Jul. 17, 2023 |
Nov. 14, 2022 |
Jun. 30, 2023 |
Mar. 06, 2023 |
|
| Subsequent Event [Line Items] | ||||
| Number of positions eliminated, period percent | 40.00% | |||
| Expected cost | $ 1.8 | |||
| Subsequent Event | ||||
| Subsequent Event [Line Items] | ||||
| Expected non-cash expense | $ 0.3 | |||
| Subsequent Event | Neoleukin [Member] | Merger Agreement [Member] | ||||
| Subsequent Event [Line Items] | ||||
| Business combination termination fee | $ 12.0 | |||
| Business combination reimbursement of expenses | 1.0 | |||
| Subsequent Event | Neurogene [Member] | Neoleukin [Member] | Merger Agreement [Member] | ||||
| Subsequent Event [Line Items] | ||||
| Business combination termination fee | 3.0 | |||
| Business combination reimbursement of expenses | $ 1.0 | |||
| Subsequent Event | Forecast [Member] | ||||
| Subsequent Event [Line Items] | ||||
| Number of positions eliminated, period percent | 70.00% | |||
| Subsequent Event | Minimum | ||||
| Subsequent Event [Line Items] | ||||
| Expected cost | 2.5 | |||
| Subsequent Event | Maximum | ||||
| Subsequent Event [Line Items] | ||||
| Expected cost | $ 3.0 |